Login to Your Account



Finding hemo: ISTH near, Shire re-casts Baxalta line after releasing bigger fish

By Randy Osborne
Staff Writer

Thursday, July 6, 2017

With the annual ISTH congress about to begin in Berlin, Shire plc disclosed its bid for another try in hemophilia with a candidate from the hopper of Baxalta Inc., acquired for $32 billion last year.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription